BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lafferty L, Rance J, Grebely J, Dore GJ, Lloyd AR, Treloar C; SToP-C Study Group. Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting. Int J Drug Policy 2020;77:102693. [PMID: 32045828 DOI: 10.1016/j.drugpo.2020.102693] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lafferty L, Rance J, Dore GJ, Lloyd AR, Treloar C. The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting. Addiction 2021;116:1162-71. [PMID: 33006784 DOI: 10.1111/add.15277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Sazzad HMS, McCredie L, Treloar C, Lloyd AR, Lafferty L. Violence and hepatitis C transmission in prison-A modified social ecological model. PLoS One 2020;15:e0243106. [PMID: 33259565 DOI: 10.1371/journal.pone.0243106] [Reference Citation Analysis]
3 Treloar C, Schroeder S, Lafferty L, Marshall A, Drysdale K, Higgs P, Baldry E, Stoove M, Dietze P. Structural competency in the post-prison period for people who inject drugs: A qualitative case study. Int J Drug Policy 2021;95:103261. [PMID: 33990057 DOI: 10.1016/j.drugpo.2021.103261] [Reference Citation Analysis]
4 Rance J, Lafferty L, Treloar C; SToP-C Study Group. Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the 'Surveillance and Treatment of Prisoners with Hepatitis C' project (SToP-C). Addiction 2021;116:2761-9. [PMID: 33751739 DOI: 10.1111/add.15477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Rance J, Lafferty L, Treloar C; SToP-C Study Group. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C). Harm Reduct J 2021;18:46. [PMID: 33902595 DOI: 10.1186/s12954-021-00494-4] [Reference Citation Analysis]
6 Lim AG, Stone J, Hajarizadeh B, Byrne M, Chambers GM, Martin NK, Grebely J, Dore GJ, Lloyd AR, Vickerman P. Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in Prisons. Hepatology 2021;74:2366-79. [PMID: 34105797 DOI: 10.1002/hep.32002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]